{"id":"985","presentation":"SAFETY AND IMMUNOGENICITY OF V114, A 15-VALENT PNEUMOCOCCAL CONJUGATE VACCINE (PCV), IN ADULTS INFECTED WITH HUMAN IMMUNODEFICIENCY VIRUS (HIV): A PHASE 3 TRIAL","session":"Vaccines - Pneumococcal Vaccines Development","filename":"V114-018 ISPPD 2020 Poster_FINAL_10Jun20.pdf","speaker":"Jakub K. Simon, United States of America","photo":"","cover":"https:\/\/s3.eu-central-1.amazonaws.com\/eu-cslide-prod-presentations\/isppd20\/985\/jpg\/v114-018isppd2020poster_final_10jun20\/thumbnails\/0.png","pdf":"\/file_access\/get_file\/E6573\/session_token\/4cb4a082efd733fda1aa38de65620e75","what":"pdf","code":"","priority":["html5","pdf","jpg","thumbnail"]}
[speaker]
[presentation]
[session]